BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8024993)

  • 1. Clinical feminisation and sex hormone concentrations in Nigerian men with cirrhosis with and without hepatocellular carcinoma.
    Olubuyide IO; Ola OS
    Br J Clin Pract; 1994; 48(2):70-2. PubMed ID: 8024993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low serum testosterone: a special feature of hepatocellular carcinoma.
    Lampropoulou-Karatzas C; Goritsas P; Makri MG
    Eur J Med; 1993 Jan; 2(1):23-7. PubMed ID: 8258001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum testosterone:estradiol ratio and the development of hepatocellular carcinoma among male cirrhotic patients.
    Tanaka K; Sakai H; Hashizume M; Hirohata T
    Cancer Res; 2000 Sep; 60(18):5106-10. PubMed ID: 11016636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocellular carcinoma in alcoholic cirrhosis: is sex hormone imbalance a pathogenetic factor?
    Farinati F; De Maria N; Marafin C; Fagiuoli S; Della Libera G; Naccarato R
    Eur J Gastroenterol Hepatol; 1995 Feb; 7(2):145-50. PubMed ID: 7712307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gonadal dysfunctions in liver cirrhosis].
    Morimoto I
    Nihon Rinsho; 1994 Jan; 52(1):132-7. PubMed ID: 8114282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oestradiol and testosterone blood levels in patients with viral cirrhosis and hepatocellular carcinoma.
    Pignata S; Daniele B; Galati MG; Esposito G; Vallone P; Fiore F; Ricchi P; Pergola M
    Eur J Gastroenterol Hepatol; 1997 Mar; 9(3):283-6. PubMed ID: 9096431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen-oestrogen imbalance in men with chronic alcoholism and fatty liver.
    Myking O; Aakvaag A; Digranes O
    Alcohol Alcohol; 1987; 22(1):7-15. PubMed ID: 3593486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor beta1 and soluble Fas serum levels in hepatocellular carcinoma.
    Sacco R; Leuci D; Tortorella C; Fiore G; Marinosci F; Schiraldi O; Antonaci S
    Cytokine; 2000 Jun; 12(6):811-4. PubMed ID: 10843770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiopoietin-2 serum levels are elevated in patients with liver cirrhosis and hepatocellular carcinoma.
    Scholz A; Rehm VA; Rieke S; Derkow K; Schulz P; Neumann K; Koch I; Pascu M; Wiedenmann B; Berg T; Schott E
    Am J Gastroenterol; 2007 Nov; 102(11):2471-81. PubMed ID: 17581268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. May plasma cholesterol level be considered a neoplastic marker in liver disease from cirrhosis to hepatocellular carcinoma?
    Venturini I; Amedei R; Modonesi G; Cosenza R; Miglioli L; Cioni G; Zeneroli ML
    Ital J Gastroenterol Hepatol; 1999; 31(1):61-5. PubMed ID: 10091105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum erythropoietin measurements by a one-step sandwich enzyme linked immunosorbent assay in patients with hepatocellular carcinoma and liver cirrhosis.
    Sawabe Y; Iida S; Tabata Y; Yonemitsu H
    Jpn J Clin Oncol; 1993 Oct; 23(5):273-7. PubMed ID: 7693989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogens, testosterone and sex hormone binding globulin in relation to liver cancer in men.
    Kuper H; Mantzoros C; Lagiou P; Tzonou A; Tamimi R; Mucci L; Benetou V; Spanos E; Stuver SO; Trichopoulos D
    Oncology; 2001; 60(4):355-60. PubMed ID: 11408804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated plasma levels of matrix metalloproteinase-9 (92-kd type IV collagenase/gelatinase B) in hepatocellular carcinoma.
    Hayasaka A; Suzuki N; Fujimoto N; Iwama S; Fukuyama E; Kanda Y; Saisho H
    Hepatology; 1996 Nov; 24(5):1058-62. PubMed ID: 8903375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum selenium concentration in patients with liver cirrhosis and hepatocellular carcinoma.
    Buljevac M; Romić Z; Vucelić B; Banić M; Krznarić Z; Plesko S
    Acta Med Croatica; 1996; 50(1):11-4. PubMed ID: 8776109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased IGF-I : IGFBP-3 ratio in patients with hepatocellular carcinoma.
    Mattera D; Capuano G; Colao A; Pivonello R; Manguso F; Puzziello A; D'Agostino L
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):699-706. PubMed ID: 14974910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does the concentration of alpha 1-proteinase inhibitor reflect the transformation of liver cirrhosis to liver carcinoma?
    Dabrowska M; Mantur M; Panasiuk A; Prokopowicz J
    Neoplasma; 1997; 44(5):305-7. PubMed ID: 9473790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex steroids and bone turnover markers in men with symptomatic vertebral fractures.
    Tuck SP; Scane AC; Fraser WD; Diver MJ; Eastell R; Francis RM
    Bone; 2008 Dec; 43(6):999-1005. PubMed ID: 18817902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The significance of serum levels of adiponectin, leptin, and hyaluronic acid in hepatocellular carcinoma of cirrhotic and noncirrhotic patients.
    Sadik NA; Ahmed A; Ahmed S
    Hum Exp Toxicol; 2012 Apr; 31(4):311-21. PubMed ID: 22249387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine evaluation in liver cirrhosis and hepatocellular carcinoma.
    Cheng KS; Tang HL; Chou FT; Chou JW; Hsu CH; Yu CJ; Kao ST; Li TC
    Hepatogastroenterology; 2009; 56(93):1105-10. PubMed ID: 19760951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High plasma concentrations of nitrite/nitrate in patients with hepatocellular carcinoma.
    Moriyama A; Masumoto A; Nanri H; Tabaru A; Unoki H; Imoto I; Ikeda M; Otsuki M
    Am J Gastroenterol; 1997 Sep; 92(9):1520-3. PubMed ID: 9317076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.